The cost-utility of sequential adjuvant trastuzumab in women with Her2/Neu-positive breast cancer: an analysis based on updated results from the HERA Trial (Q83978545)
Jump to navigation
Jump to search
scientific article published on 01 July 2009
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | The cost-utility of sequential adjuvant trastuzumab in women with Her2/Neu-positive breast cancer: an analysis based on updated results from the HERA Trial |
scientific article published on 01 July 2009 |
Statements
The cost-utility of sequential adjuvant trastuzumab in women with Her2/Neu-positive breast cancer: an analysis based on updated results from the HERA Trial (English)